US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Mar 23, 2023 (3 years ago)

Rosuvastatin Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

What was recalled

Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

Recalling firm
Preferred Pharmaceuticals, Inc.
NDC code
68788-7086-3
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0519-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Rosuvastatin recalls

See all
Class II · Moderate risk Ongoing

Rosuvastatin Tablets

Reason Out of specification for dissolution.

AvKARE D-0292-2026
Class II · Moderate risk Ongoing

Rosuvastatin Tablets 40mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-264-30 D-0339-2025
Class II · Moderate risk Ongoing

Rosuvastatin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-7971-3 D-0520-2023
Class II · Moderate risk Terminated

Rosuvastatin 40mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1311-01 D-0502-2023
Class II · Moderate risk Terminated

Rosuvastatin 10mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0375-03 D-0501-2023